Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Akeso Announces Oral Presentation of Ivonescimab (PD-1/VEGF Bi-Specific) in First-line Treatment of ES-SCLC on ACLC 2022 2022-10-31 08:40
GenesisCare and PreludeDx(TM) present compelling Australian-first DCISionRT Study Interim Analysis during Breast Cancer Awareness Month 45% change in treatment recommendations when using DCISionRT 2022-10-31 05:00
Nuevocor to Present Pre-clinical Data on its Gene Therapy Candidate for LMNA Dilated Cardiomyopathy at American Heart Association Scientific Sessions 2022 2022-10-28 22:30
LISCure Biosciences Announces Oral Presentation of New Drug Candidate for NASH at Upcoming AASLD The Liver Meeting 2022 2022-10-28 21:00
Hinova Disclosed the Preclinical Results of HP518 (Oral AR PROTAC) at the 5th Annual TPD Summit 2022-10-28 20:30
NDA for New Second-Line Indication of CAR T-Cell Therapy Product YIKAIDA (Axicabtagene Ciloleucel Injection) Approved for CDE Review 2022-10-28 01:37
WuXi Biologics Provides Corporate Updates 2022-10-27 22:13
Simcere Receives FDA Clearance of Investigational New Drug Application (IND) for Bi-functional Fusion Protein, SIM0237 2022-10-27 21:25
Kintor Pharma Announces Completion of Subject Enrollment and Dosing in Phase I Clinical Trial of AR-PROTAC(GT20029) in the US 2022-10-27 21:22
Antengene to Host Research and Development Day on November 15th and 17th, 2022 2022-10-27 11:07
Samsung Biologics Reports Third Quarter 2022 Financial Results 2022-10-27 07:35
Alterity Therapeutics Announces Presentation of MRI Data from the bioMUSE Natural History Study at the American Neurological Association Annual Meeting 2022-10-26 19:25
Yiling Pharmaceutical Exhibiting its Innovative TCM Products during CHEXPO Macau 2022 2022-10-26 16:52
ImmVira announced its signing of Series C+ financing and negotiation with further investors for the round 2022-10-26 14:26
SK bioscience and CEPI Sign Agreement to Develop mRNA Vaccines 2022-10-25 20:00
FDA Accepts NMP's Clinical Trial Application for Development of NMK89 as Imaging Agent for Cancer Diagnosis 2022-10-25 16:00
WuXi Biologics Released a New cGMP Drug Product Manufacturing Facility to Support End-to-End Services for Diversified Modalities 2022-10-24 08:30
SK bioscience Appoints New Executives towards Global Business Growth 2022-10-21 20:00
Harbour BioMed Announces Dosing of First Patient in Phase I Trial of B7H4x4-1BB Bispecific Antibody in the United States 2022-10-20 16:20
AASLD 2022 | Ascentage Pharma to Announce Results from First-in-Human Study of IAP Antagonist APG-1387 in an Oral Report at the AASLD Annual Meeting 2022-10-20 07:16
1 65 66 67 68 69 165